Reaxa sets up Indian subsidiary

Related tags India Corporation United kingdom

Reaxa will set up an Indian subsidiary to manage supply chain, commercial scale production and application development for its growing number of customers in the country.

The firm, which specialises in industrial catalysis with its EnCat immobilised technology, is launching Reaxa India using funds raised through investments by UK groups Enterprise Ventures and YFM Private Equity and India’s S Amit & Co.

S Amit & Co, which already sells Reaxa’s EnCat and QuadraPure technologies to customers in India, will begin commercial sales of its Nickel EnCat range in the country in the near future.

Reaxa sales director Ed Dutton said that sees Reaxa India as the next step towards establishing a commercial manufacturing presence in India.

Related news

Show more

Related products

Efficient Freezing & Storage of Biopharmaceuticals

Efficient Freezing & Storage of Biopharmaceuticals

Content provided by Single Use Support | 06-Nov-2023 | White Paper

Various options exist for freezing biopharmaceutical bulk material, but selecting the most effective and efficient approach for each cold chain can be...

Follow us

Webinars

Headlines